Clincosm LogoSign in Get a demo

recurrent esophageal cancer

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in

Terminated
Has Results
  • Adenocarcinoma of the Esophagus
  • +13 more
  • oblimersen sodium
  • +2 more
  • Bronx, New York
    Montefiore Medical Center
Jan 29, 2021

European iNvestigation of SUrveillance After Resection for

Completed
  • Esophageal Cancer
  • +6 more
  • High intensity postoperative oncologic surveillance
  • Dublin, Ireland
  • +2 more
Mar 25, 2020

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in

Completed
Has Results
  • Adenocarcinoma of the Esophagus
  • +8 more
  • Duarte, California
  • +2 more
Apr 26, 2017

Adenocarcinoma of the Esophagus, Adenocarcinomas of the Gastroesophageal Junction, Recurrent Esophageal Cancer Trial in Columbus

Completed
Has Results
  • Adenocarcinoma of the Esophagus
  • +4 more
  • Columbus, Ohio
    Ohio State University
Apr 25, 2016

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Advanced Adult Primary Liver Cancer Trial in Nashville (cetuximab,

Completed
  • Adenocarcinoma of the Colon
  • +66 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Sep 28, 2015

Adenocarcinoma of the Esophagus, Recurrent Esophageal Cancer, Stage IV Esophageal Cancer Trial in Chicago (triapine, cisplatin)

Completed
  • Adenocarcinoma of the Esophagus
  • +2 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Oct 7, 2013

Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix, Estrogen Receptor-negative Breast Cancer Trial in

Completed
  • Advanced Adult Primary Liver Cancer
  • +87 more
  • Charlottesville, Virginia
    University of Virginia
Sep 27, 2013

Adenocarcinoma of the Gastroesophageal Junction, HER2-positive Breast Cancer, Male Breast Cancer Trial in New York (drug,

Terminated
  • Adenocarcinoma of the Gastroesophageal Junction
  • +11 more
  • Akt inhibitor MK2206
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Sep 27, 2013

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer Trial in New York

Completed
  • Adenocarcinoma of the Esophagus
  • +5 more
  • erlotinib hydrochloride
  • laboratory biomarker analysis
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 3, 2013

Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,

Completed
  • Advanced Adult Primary Liver Cancer
  • +126 more
  • recombinant interleukin-12
  • ABI-007/carboplatin/trastuzumab
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 27, 2013

Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Chicago (erlotinib HCl,

Completed
  • Adult Anaplastic Astrocytoma
  • +85 more
  • erlotinib hydrochloride
  • laboratory biomarker analysis
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jan 15, 2013